Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

843
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
843
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

789
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
789
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.8K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

568
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
568
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

905
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
905

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Selective Sphingosine-1-Phosphate Receptor 1 Agonist, TRV045, on Evoked Pain Tests: An Exploratory, Four-Way Cross-Over Study in Healthy Volunteers.

European journal of pain (London, England)·2026
Same author

Combination of the BK-Channel Antagonist ENA-001 and Naloxone Is More Effective Than Either Agent Alone in Reversing Fentanyl-Induced Respiratory Suppression in Rats.

Cureus·2026
Same author

Corrigendum to 'Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility' (Br J Anaesth 2026; 136: 1459-71).

British journal of anaesthesia·2026
Same author

Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study.

Pharmacoepidemiology and drug safety·2026
Same author

<i>In Vivo</i> Detection of Nitrous Oxide in Blood and Saliva Following Recreational Use.

ACS omega·2026
Same author

Effect of Paroxetine or Escitalopram Coadministered with Oxycodone versus Oxycodone Alone on Ventilation during Hypercapnia: A Randomized Clinical Trial.

Anesthesiology·2026
Same journal

Advancing global health economics and policy of palliative and end-of-life care: insights from Ireland, Norway, Finland, Argentina, and India.

Annals of palliative medicine·2026
Same journal

Immune-related adverse effects in palliative care clinic.

Annals of palliative medicine·2026
Same journal

Palliative care for patients with haematologic malignancies: challenges and opportunities.

Annals of palliative medicine·2026
Same journal

Metastatic brachial plexopathy presenting as radiation-induced plexopathy in metastatic lung cancer: a case report and literature review.

Annals of palliative medicine·2026
Same journal

Artificial intelligence in home-based serious illness care: a scoping review of applications supporting quality palliative care.

Annals of palliative medicine·2026
Same journal

Christian and Indian religions on palliative sedation: a scoping study.

Annals of palliative medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 1, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.0K

Opioid utility function: methods and implications.

Cornelis Jan van Dam1, Marijke Hyke Algera1, Erik Olofsen1

  • 1Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.

Annals of Palliative Medicine
|December 24, 2019
PubMed
Summary
This summary is machine-generated.

Opioid utility functions balance analgesia benefits against harms like respiratory depression (RD). These functions aid clinicians in selecting safer, more effective pain relief options by comparing opioid risk-benefit profiles.

Keywords:
Painanalgesiabenefitharmopioidrespiratory depression (RD)utilityutility function

More Related Videos

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.7K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.1K

Related Experiment Videos

Last Updated: Jan 1, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.0K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.7K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.1K

Area of Science:

  • Pharmacology
  • Decision Science
  • Pain Management

Background:

  • Opioids offer analgesia but cause adverse effects, including life-threatening respiratory depression (RD).
  • Evaluating opioid benefits versus harms is crucial for safe and effective pain management.
  • Economic principles, using utility functions, can quantify this benefit-harm balance.

Purpose of the Study:

  • To define and apply opioid utility functions to assess the risk-benefit profile of various opioids.
  • To explore different utility function models, including those focusing on analgesia without RD.
  • To demonstrate how utility functions can inform clinical decision-making for pain relief.

Main Methods:

  • Development of utility functions (U = P(benefit) - P(harm)) based on pharmacokinetic and pharmacodynamic data.
  • Analysis of utility functions for specific opioids: buprenorphine, fentanyl, alfentanil, and cebranopadol.
  • Consideration of utility surfaces and pragmatic utility functions when data is limited.

Main Results:

  • Utility functions provide a quantitative measure to compare opioid analgesia versus RD risk.
  • Different opioids exhibit varying utility profiles, influencing their suitability for specific patient populations.
  • Subpopulation-specific utility functions are essential for personalized pain management.

Conclusions:

  • Opioid utility functions empower clinicians to make informed analgesic choices.
  • Prioritizing opioids with positive utility functions can optimize pain relief while minimizing harm.
  • Tailoring opioid selection based on subgroup-specific utility data enhances patient safety and treatment efficacy.